Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Chinese Patent Office

Generated: July 26, 2017

DrugPatentWatch Database Preview

Hydrocortisone acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrocortisone acetate and what is the scope of hydrocortisone acetate freedom to operate?

Hydrocortisone acetate
is the generic ingredient in nineteen branded drugs marketed by Colgate, Ingram Pharm, Parke Davis, Watson Labs, Pharmacia And Upjohn, Merck, Cenci, Fera Pharms, Akorn, Bel Mar, Purepac Pharm, Mylan Speciality Lp, Ferndale Labs, Pfizer, Able, X Gen Pharms, Sebela Ireland Ltd, Monarch Pharms, Vintage Pharms, Fougera Pharms, and Taro, and is included in forty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixty drug master file entries for hydrocortisone acetate. Three suppliers are listed for this compound.

Summary for Generic Name: hydrocortisone acetate

Drug Master File Entries: see list60
Suppliers / Packagers: see list3
Bulk Api Vendors: see list52
Clinical Trials: see list1,169
Patent Applications: see list7,424
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydrocortisone acetate at DailyMed

Pharmacology for Ingredient: hydrocortisone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
hydrocortisone acetate; urea
CREAM;TOPICAL089472-001Jun 13, 1988RXNoNo► Subscribe► Subscribe► Subscribe
X Gen Pharms
hydrocortisone acetate
POWDER;FOR RX COMPOUNDING085981-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
hydrocortisone acetate; neomycin sulfate
OINTMENT;OPHTHALMIC060610-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sebela Ireland Ltd
hydrocortisone acetate; pramoxine hydrochloride
CREAM;TOPICAL083778-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
hydrocortisone acetate
OINTMENT;OPHTHALMIC, OTIC009018-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
US Army
Argus Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:

Google Plus